228 related articles for article (PubMed ID: 17606205)
1. The model for end-stage liver disease comes of age.
Freeman RB
Clin Liver Dis; 2007 May; 11(2):249-63. PubMed ID: 17606205
[TBL] [Abstract][Full Text] [Related]
2. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
3. Model for end-stage liver disease (MELD) exception guidelines.
Wiesner R; Lake JR; Freeman RB; Gish RG
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S85-7. PubMed ID: 17123285
[No Abstract] [Full Text] [Related]
4. The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.
Medici V; Rossaro L; Wegelin JA; Kamboj A; Nakai J; Fisher K; Meyers FJ
Liver Transpl; 2008 Aug; 14(8):1100-6. PubMed ID: 18668666
[TBL] [Abstract][Full Text] [Related]
5. [The value of MELD in the allocation of priority for liver transplantation candidates].
Colmenero J; Castro-Narro G; Navasa M
Gastroenterol Hepatol; 2010 Apr; 33(4):330-6. PubMed ID: 19631411
[TBL] [Abstract][Full Text] [Related]
6. Model for end-stage liver disease (MELD) exception for polycystic liver disease.
Arrazola L; Moonka D; Gish RG; Everson GT
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S110-1. PubMed ID: 17123287
[No Abstract] [Full Text] [Related]
7. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
[TBL] [Abstract][Full Text] [Related]
8. Model for end-stage liver disease (MELD) exception for unusual metabolic liver diseases.
McDiarmid S; Gish RG; Horslen S; Mazariegos GV
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S124-7. PubMed ID: 17123278
[No Abstract] [Full Text] [Related]
9. Model for end-stage liver disease (MELD) exception for severe pruritus.
Washburn WK; Gish RG
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S119. PubMed ID: 17123292
[No Abstract] [Full Text] [Related]
10. Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems.
Gitto S; Lorenzini S; Biselli M; Conti F; Andreone P; Bernardi M
Dig Liver Dis; 2009 Oct; 41(10):700-6. PubMed ID: 19502118
[TBL] [Abstract][Full Text] [Related]
11. Model for end-stage liver disease (MELD) exception for hepatic encephalopathy.
Ham J; Gish RG; Mullen K
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S102-4. PubMed ID: 17123294
[No Abstract] [Full Text] [Related]
12. Model for end-stage liver disease (MELD) exception for ascites.
Biggins SW; Colquhoun S; Gish RG; Runyon BA
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S88-90. PubMed ID: 17123288
[No Abstract] [Full Text] [Related]
13. Model for end-stage liver disease (MELD) exception for cystic fibrosis.
Horslen S; Sweet S; Gish RG; Shepherd R
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S98-9. PubMed ID: 17123272
[No Abstract] [Full Text] [Related]
14. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
Sun J; Guo ZH; Lai TS; Tang YQ; Su L; Huo F; Wang SP; Pu MS; Wen Q
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907
[TBL] [Abstract][Full Text] [Related]
15. Model for end-stage liver disease (MELD) exception for Budd-Chiari syndrome.
Washburn WK; Gish RG; Kamath PS
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S93-4. PubMed ID: 17123293
[No Abstract] [Full Text] [Related]
16. Model for end-stage liver disease (MELD) exception for primary hyperoxaluria.
Horslen S; Gish RG; McDonald R
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S117-8. PubMed ID: 17123291
[No Abstract] [Full Text] [Related]
17. Model for end-stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia.
Garcia-Tsao G; Gish RG; Punch J
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S108-9. PubMed ID: 17123286
[No Abstract] [Full Text] [Related]
18. Model for end-stage liver disease (MELD) exception for familial amyloidotic polyneuropathy.
Pomfret E; Gish RG; Brandhagen D
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S100-1. PubMed ID: 17123281
[No Abstract] [Full Text] [Related]
19. Model for end-stage liver disease (MELD) exception for bacterial cholangitis.
Gores GJ; Gish RG; Shrestha R; Wiesner RH
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S91-2. PubMed ID: 17123280
[No Abstract] [Full Text] [Related]
20. Model for end-stage liver disease (MELD) exception small-for-size syndrome.
Sheiner P; Belghiti J; Gish RG; Miller C
Liver Transpl; 2006 Dec; 12(12 Suppl 3):S120-1. PubMed ID: 17123277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
